Biodexa Pharmaceuticals plc (BDRX) Free Cash Flow by Year
Biodexa Pharmaceuticals plc recorded an outflow of $7.5M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Biodexa Pharmaceuticals plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BDRX Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BDRX Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Biodexa Pharmaceuticals plc financials
Frequently Asked Questions
What was Biodexa Pharmaceuticals plc's free cash flow in fiscal year 2025?
Biodexa Pharmaceuticals plc recorded an outflow of $7.5M in free cash flow in fiscal year 2025.
How fast is Biodexa Pharmaceuticals plc's free cash flow growing?
Biodexa Pharmaceuticals plc (BDRX) reported an outflow of $15.4M in free cash flow in fiscal year 2024 and an outflow of $7.5M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
How has Biodexa Pharmaceuticals plc's free cash flow changed over the years?
Across the 11 fiscal years this page covers, Biodexa Pharmaceuticals plc (BDRX) free cash flow went from -$19.7M in fiscal year 2015 to -$7.5M in fiscal year 2025.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Biodexa Pharmaceuticals plc (BDRX) reported on that line in every period on record.